Treating the causes of paediatric hypertension using non-invasive physiological parameters

Related Experiment Video

Updated: Jun 13, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Joe Brierley1, Stephen D Marks

  • 1Paediatric and Neonatal Intensive Care Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Medical Hypotheses
|May 7, 2010
PubMed

Insights

Pediatric hypertension management can be improved by using new non-invasive hemodynamic monitoring. Tailoring treatments to individual physiological derangements offers more effective blood pressure control in children.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Physiology
  • Clinical Pharmacology

Background:

  • Hypertension in children, particularly those with renal disease, presents diagnostic and therapeutic challenges.
  • Recent advancements in understanding blood pressure homeostasis (renin-angiotensin system, endothelial function) and hypertensive pathophysiology exist.
  • Current pediatric hypertension treatment strategies often lack personalization, failing to address individual physiological derangements.

Purpose of the Study:

  • To advocate for the integration of non-invasive hemodynamic monitoring in pediatric hypertension management.
  • To propose a shift towards individualized, physiology-targeted antihypertensive therapies in children.
  • To explore the application of hemodynamic parameters, typically used in intensive care, for outpatient pediatric hypertension management.

Main Methods:

  • Review of current knowledge on pediatric hypertension and blood pressure regulation.
  • Discussion of emerging non-invasive technologies for quantifying hemodynamic parameters (cardiac index, systemic vascular resistance).
  • Proposal of a treatment algorithm based on individual hemodynamic profiles.

Main Results:

  • Non-invasive technologies can quantify key hemodynamic parameters (e.g., cardiac index, systemic vascular resistance).
  • Mean arterial pressure is determined by cardiac output and systemic vascular resistance.
  • Specific antihypertensive strategies can be logically derived from these parameters (e.g., beta-blockers for elevated cardiac index, vasodilators for elevated systemic vascular resistance).

Conclusions:

  • Individualized, physiology-targeted therapies for pediatric hypertension promise greater efficacy and speed.
  • Non-invasive hemodynamic assessment enables tailored treatment selection, moving beyond physician preference.
  • The application of advanced hemodynamic monitoring in outpatient settings can significantly improve pediatric hypertension management.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...